Bacterial genomes pave the way to novel vaccines.
The availability of complete genome sequences of pathogens has dramatically changed the scope for developing improved and novel vaccines by increasing the speed of target identification. Genomics-based technologies have many advantages, compared to conventional approaches, which are time-consuming and usually identify only abundant antigens that are expressible under in vitro culture conditions. This review focuses on recent reports of genomics-based strategies that can be applied to most pathogens and that exploit genome sequence information in alliance with adjunct technologies, including bioinformatics, expression analyses, random mutagenesis or protein/peptide-based selection methods. Despite the caveats that are associated with the individual approaches, these technologies have already made major contributions to the identification and selection of novel vaccine candidates to combat bacterial infections.
Meinke
Andreas
A
Intercell AG, Campus Vienna Biocenter 6, A-1030 Vienna, Austria.
Henics
Tamas
T
Nagy
Eszter
E
D001424:Bacterial Infections / Q000517:prevention & control; D001428:Bacterial Vaccines; D019295:Computational Biology; D015195:Drug Design; D020869:Gene Expression Profiling; D016680:Genome, Bacterial; D023281:Genomics; D006801:Humans; D016296:Mutagenesis; D014158:Transcription, Genetic
D001428:Bacterial Vaccines